SEC Form D · filed October 9, 2024
Bectas Therapeutics, Inc
Offering
$10.0M
Sold
$4.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOUSTON, TX
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (4)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗